Menu
Bayee Biotech(Anqing)Co.,Ltd logo

Bayee Biotech(Anqing)Co.,Ltd

Bayee Biotech(Anqing)Co.,Ltd Main Image

Bayee Biotech Co., Ltd is a high_tech manufactory, which is committed to producing high quality pharmaceutical intermediates, promoting innovation in API technology and provide customized services for global pharmaceutical companies. We keep good quality and competitive prices for global valued customers.

Conpany profile:
Office located in Hightech industrial development zone No. 8, Huangguan Road, Daguan District, Anqing, Anhui Province, 200 workers, more than 10 years experience, Exhibitors of CPhI China 2020, CE & FDA certificate is under the process, will finish in 1 year. Currently we have 16 cooperative companies in Southeast Asia ,India and Spain.
Factory profile:
Located in Changzhi, Shanxi including 2500 square meter analysis laboratories equipped with HPLC, GC and other analytical facilities.
One pilot and two mass production workshop with more than 70 glass lined reactors, total reaction capacity can reach 35000L.

Latest main product:
Parecoxib sodium,Brivaracetam,Canagliflozin,Empagliflozin,Dapagliflozin,Tofacitinib,Pimavanserin,Crisaborole,Vonoprazan Fumarate,Tolvaptan ,Febuxostat,Brexpiprazole,Apixaban,Rivaroxaban,Eltrombopag,Ticagrelor,Avatrombopag,Baricitinib,Ruxolitinib,Upadacitinib,Dabigatran,Tavaborole,Finafloxacin Hydrochloride,Topiroxostat
(All products above can be sold in API and intermediates)
Provid:
MOA
ROS
COA
MSDS
GMP Standard
ISO9001:2008 Quality System Certification

Research and provide synthetic process services:
Brivaracetam, Riociguat, Urapidil, Norepinephrine, Empagliflozin, Baricitinib, Upadacitinib, Tavaborole, Finafloxacin, Crisaborole, Ruxolitinib
At the same time, we also provide a full set of services for testing and registering drugs apply to the China National FDA till you get the China National FDA certificate

Parecoxib Sodium API & Intermediates Parecoxib Sodium API & Intermediates
1/2
Ruxolitinib API & Intermediates Ruxolitinib API & Intermediates
1/2
Tofacitinib citrate API & Intermediates Tofacitinib citrate API & Intermediates
1/2
Crisaborole API & Intermediates Crisaborole API & Intermediates
1/2

Company Profile

Membership: On ECPlaza since 2020
Business Type: Manufacturer, Service
Location: Anhui, China
Product Category: Other Drugs
Main Item / Product: API (Active Pharmaceutical Ingredient) & Intermediate
Keywords: Api & Intermediate
Main Markets:
  • South Asia 67%
  • Western Europe 33%
Safety / Quality Approvals: GMP Standard
Representative / CEO's Name: Deguang Heng
Year Established: 2009
Employees Total: 40 to 49
Annual Revenue: More than US$1,000,000
Annual Export Rate: 50%

Products

Empagliflozin API & Intermediates Empagliflozin API & Intermediates
1/2
Rivaroxaban API & Intermediates Rivaroxaban API & Intermediates
1/2
Pimavanserin API & Intermediates Pimavanserin API & Intermediates
1/2
Baricitinib API & Intermediates Baricitinib API & Intermediates
1/2
Vonoprazan Fumarate API & Intermediates Vonoprazan Fumarate API & Intermediates
1/2
Apixaban API & Intermediates Apixaban API & Intermediates
1/2
Tolvaptan API & Intermediates Tolvaptan API & Intermediates
1/2
Roxadustat API & Intermediates Roxadustat API & Intermediates
1/2
Brexpiprazole API & Intermediates Brexpiprazole API & Intermediates Brexpiprazole API & Intermediates
1/3

Contact Information

Company Name
Bayee Biotech(Anqing)Co.,Ltd

Contact Person
Leon Shen

Address
No. 8, Huangguan Road, Daguan District

City/Area
Anqing

State/Province
Anhui

Zip/Postal Code
246000

Country/Region
China

Telephone
+86 178 5560 6542

Website

Website on ecplaza.net

Contact Now

Contact Now